Search results for: rituximab

Updated Perioperative Guideline Released: Recommendations Balance Risks of Infection & Disease Flare

Ruth Jessen Hickman, MD | September 13, 2022

The 2017 recommendations are updated to reflect changes in medical literature, as well as to include newly approved drugs.

What’s New in SLE: Pathogenesis & Novel Therapies

Samantha C. Shapiro, MD | September 8, 2022

Thomas Dörner, MD, reviewed the current state of systemic lupus erythematosus (SLE) management, providing updates on novel therapies and insights into the pathogenesis of SLE.

A Young Disease: A Holistic Approach to the Treatment of Antiphospholipid Syndrome

Samantha C. Shapiro, MD | September 8, 2022

Although progress has been made in recent years, rheumatologists still have a lot of questions regarding best management practices for antiphospholipid syndrome (APS). During a session of EULAR 2022, Ricard Cervera, MD, PhD, described a holistic approach.

A Vessel for Knowledge: The Latest Research & Management Updates for Vasculitis

Jason Liebowitz, MD, FACR | August 11, 2022

Brendan Antiochos, MD, provided a timely update on research and treatments related to vasculitis, addressing treatments for ANCA-associated vasculitis and giant cell arteritis, COVID-19 vaccination and more.

Just in Case: Understanding Rheumatoid Arthritis Through Patient Cases

Jason Liebowitz, MD, FACR | August 11, 2022

Uzma Haque, MD, addressed the management of difficult-to-treat rheumatoid arthritis, using patient case reports to demonstrate clinical decision-making, during a session of the 18th Annual Advances in the Diagnosis & Treatment of the Rheumatic Diseases symposium.

Clinical Challenges in SLE: Glucocorticoids—How Much Is Too Much?

Samantha C. Shapiro, MD | July 22, 2022

Glucocorticoids remain a prominent part of care for many patients with SLE but can have toxic side effects; this EULAR 2022 session discussed one institution’s approach to lower the dosage.

Difficult-to-Treat Lupus: When & How to Use New Therapies

Samantha C. Shapiro, MD | July 21, 2022

Clinicians have numerous treatment options for SLE; in a EULAR 2022 session, some of the newer therapies were reviewed.

Clinical Guidance & Recommendation Updates for Vasculitis, axSpA & More

Jason Liebowitz, MD, FACR | July 15, 2022

In this EULAR 2022 session, new & revised treatment recommendations for ANCA-associated vasculitis, axial spondyloarthritis & rheumatoid arthritis were presented.

FDA Approves Riabni, a Rituxumab Biosimilar, to Treat Patients with RA

Michele B. Kaufman, PharmD, BCGP | July 13, 2022

Based on findings from a double-blind, placebo-controlled study evaluating its efficacy and safety, rituximab-arrx has received FDA approval for the treatment of patients with rheumatoid arthritis.

Pearls of Wisdom from an Expert: Challenging ILD Cases with a Pulmonologist-Rheumatologist

Samantha C. Shapiro, MD | June 17, 2022

Erin Wilfong, MD, PhD, shared her niche expertise in connective tissue disease ILD (CTD-ILD) via case-based learning during a session of the 2022 ACR Education Exchange.